Skip to main content
Erschienen in: Documenta Ophthalmologica 3/2013

01.12.2013 | Review Article

Role of visual evoked potentials in the assessment and management of optic pathway gliomas in children

verfasst von: C. Van Mierlo, W. Spileers, E. Legius, I. Casteels, C. Cassiman

Erschienen in: Documenta Ophthalmologica | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim of this study is to investigate the role of pattern reversal visual evoked potentials (pVEPs) in the screening and monitoring of optic pathway gliomas (OPGs) in children with and without neurofibromatosis type 1.

Methods

A review of the English literature published between 1980 and 2012 was performed, with comparison of results of retro- and prospective studies.

Results

Pattern reversal VEPs have a high sensitivity (85.7–100 %) for the diagnosis of OPGs, moreover they are safe and cost-effective. Conversely, they have a low specificity (43–83 %) and are not widely available. Besides, pattern reversal VEP results can be unreliable in young children, because of the need for a good cooperation. The studies that were analyzed have drawbacks, including the small sample size, the retrospective design, the differences in gold standard for diagnosis, the different interpretation of small changes in VEP results and the lack of control groups.

Conclusion

There is still debate about the gold standard for the screening and follow-up of OPGs. The added value of pVEPs to the ophthalmic examination is controversial. Randomized controlled trials or prospective multicentre studies are necessary to assess with sufficient accuracy the sensitivity and specificity of pattern reversal VEPs in the screening for OPGs and its follow-up.
Fußnoten
1
US Public Health Service Grading System for Rating Recommendations in Clinical Guidelines: strength of recommendation (A–E) and quality of evidence (I–III) [11].
 
Literatur
1.
Zurück zum Zitat Listernick R, Charrow J, Gutmann DH (1999) Intracranial gliomas in neurofibromatosis type 1. Am J Med Genet 89:38–44CrossRefPubMed Listernick R, Charrow J, Gutmann DH (1999) Intracranial gliomas in neurofibromatosis type 1. Am J Med Genet 89:38–44CrossRefPubMed
2.
Zurück zum Zitat Ng Y, North KN (2001) Visual-evoked potentials in the assessment of optic gliomas. Pediatr Neurol 24:44–48CrossRefPubMed Ng Y, North KN (2001) Visual-evoked potentials in the assessment of optic gliomas. Pediatr Neurol 24:44–48CrossRefPubMed
3.
Zurück zum Zitat North K, Cochineas C, Tang E, Fagan E (1994) Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials. Pediatr Neurol 10:117–123CrossRefPubMed North K, Cochineas C, Tang E, Fagan E (1994) Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials. Pediatr Neurol 10:117–123CrossRefPubMed
4.
Zurück zum Zitat Thiagalingam S, Flaherty M, Billson F, North K (2004) Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients. Ophthalmology 111:568–577CrossRefPubMed Thiagalingam S, Flaherty M, Billson F, North K (2004) Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients. Ophthalmology 111:568–577CrossRefPubMed
5.
Zurück zum Zitat Wolsey DH, Larson SA, Creel D, Hoffman R (2006) Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing? J AAPOS 10:307–311CrossRefPubMed Wolsey DH, Larson SA, Creel D, Hoffman R (2006) Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing? J AAPOS 10:307–311CrossRefPubMed
6.
7.
Zurück zum Zitat Binning MJ, Liu JK, Kestle JR, Brockmeyer DL, Walker ML (2007) Optic pathway gliomas: a review. Neurosurg Focus 23:E2CrossRefPubMed Binning MJ, Liu JK, Kestle JR, Brockmeyer DL, Walker ML (2007) Optic pathway gliomas: a review. Neurosurg Focus 23:E2CrossRefPubMed
8.
Zurück zum Zitat Lee AG (2007) Neuroophthalmological management of optic pathway gliomas. Neurosurg Focus 23:E1CrossRefPubMed Lee AG (2007) Neuroophthalmological management of optic pathway gliomas. Neurosurg Focus 23:E1CrossRefPubMed
9.
Zurück zum Zitat Shapey J, Danesh-Meyer HV, Kaye AH (2011) Diagnosis and management of optic nerve glioma. J Clin Neurosci 18:1585–1591CrossRefPubMed Shapey J, Danesh-Meyer HV, Kaye AH (2011) Diagnosis and management of optic nerve glioma. J Clin Neurosci 18:1585–1591CrossRefPubMed
10.
11.
Zurück zum Zitat Listernick R, Ferner RE, Liu GT, Gutmann DH (2007) Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 61:189–198CrossRefPubMed Listernick R, Ferner RE, Liu GT, Gutmann DH (2007) Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 61:189–198CrossRefPubMed
12.
Zurück zum Zitat Daginakatte GC, Gutmann DH (2007) Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth. Hum Mol Genet 16:1098–1112CrossRefPubMed Daginakatte GC, Gutmann DH (2007) Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth. Hum Mol Genet 16:1098–1112CrossRefPubMed
13.
Zurück zum Zitat Sharif S, Upadhyaya M, Ferner R, Majouni E, Shenton A, Baser M, Thakker N, Evans DG (2011) A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations. J Med Genet 48:256–260CrossRefPubMed Sharif S, Upadhyaya M, Ferner R, Majouni E, Shenton A, Baser M, Thakker N, Evans DG (2011) A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations. J Med Genet 48:256–260CrossRefPubMed
14.
Zurück zum Zitat Kornreich L, Blaser S, Schwarz M, Shuper A, Vishne TH, Cohen IJ, Faingold R, Michovitz S, Koplewitz B, Horev G (2001) Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatiosis. Am J Neuroradiol 22:1963–1969PubMed Kornreich L, Blaser S, Schwarz M, Shuper A, Vishne TH, Cohen IJ, Faingold R, Michovitz S, Koplewitz B, Horev G (2001) Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatiosis. Am J Neuroradiol 22:1963–1969PubMed
15.
Zurück zum Zitat Shamji MF, Benoit BG (2007) Syndromic and sporadic pediatric optic pathway gliomas: review of clinical and histopathological differences and treatment implications. Neurosurg Focus 23:E3CrossRefPubMed Shamji MF, Benoit BG (2007) Syndromic and sporadic pediatric optic pathway gliomas: review of clinical and histopathological differences and treatment implications. Neurosurg Focus 23:E3CrossRefPubMed
16.
Zurück zum Zitat Opocher E, Kremer LC, Da Dalt L, van de Wetering MD, Viscardi E, Caron HN, Perilongo G (2006) Prognostic factors for progression of childhood optic pathway glioma: a systematic review. Eur J Cancer 42:1807–1816CrossRefPubMed Opocher E, Kremer LC, Da Dalt L, van de Wetering MD, Viscardi E, Caron HN, Perilongo G (2006) Prognostic factors for progression of childhood optic pathway glioma: a systematic review. Eur J Cancer 42:1807–1816CrossRefPubMed
17.
Zurück zum Zitat Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, Packer RJ, Tabori U, Hoffman RO, Ardern-Holmes SL, Hummel TR, Hargrave DR, Bouffet E, Charrow J, Bilaniuk LT, Balcer LJ, Liu GT (2012) Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a retrospective analysis. Neuro Oncol 14:790–797CrossRefPubMed Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, Packer RJ, Tabori U, Hoffman RO, Ardern-Holmes SL, Hummel TR, Hargrave DR, Bouffet E, Charrow J, Bilaniuk LT, Balcer LJ, Liu GT (2012) Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a retrospective analysis. Neuro Oncol 14:790–797CrossRefPubMed
18.
Zurück zum Zitat Lenassi E, Likar K, Stirn-Kranjc B, Brecelj J (2008) VEP maturation and visual acuity in infants and preschool children. Doc Ophthalmol 117:111–120CrossRefPubMed Lenassi E, Likar K, Stirn-Kranjc B, Brecelj J (2008) VEP maturation and visual acuity in infants and preschool children. Doc Ophthalmol 117:111–120CrossRefPubMed
19.
Zurück zum Zitat Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, Tormens AP, Vaegan (2010) ISCEV standard for clinical visual evoked potentials (2009 update). Doc Ophthalmol 120:111–119 Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, Tormens AP, Vaegan (2010) ISCEV standard for clinical visual evoked potentials (2009 update). Doc Ophthalmol 120:111–119
20.
Zurück zum Zitat Tobimatsu S, Celesia GG (2006) Studies of human visual pathophysiology with visual evoked potentials. Clin Neurophysiol 117:1414–1433CrossRefPubMed Tobimatsu S, Celesia GG (2006) Studies of human visual pathophysiology with visual evoked potentials. Clin Neurophysiol 117:1414–1433CrossRefPubMed
21.
Zurück zum Zitat Halliday AM, Mushin J (1980) The visual evoked potential in neuroophthalmology. Int Ophthalmol Clin 20:155–183CrossRefPubMed Halliday AM, Mushin J (1980) The visual evoked potential in neuroophthalmology. Int Ophthalmol Clin 20:155–183CrossRefPubMed
22.
Zurück zum Zitat Taylor MJ, McCulloch DL (1992) Visual evoked potentials in infants and children. J Clin Neurophysiol 9:357–372CrossRefPubMed Taylor MJ, McCulloch DL (1992) Visual evoked potentials in infants and children. J Clin Neurophysiol 9:357–372CrossRefPubMed
23.
Zurück zum Zitat Kriss A, Russell-Eggitt I (1992) Electrophysiological assessment of visual pathway function in infants. Eye 6:145–153CrossRefPubMed Kriss A, Russell-Eggitt I (1992) Electrophysiological assessment of visual pathway function in infants. Eye 6:145–153CrossRefPubMed
24.
Zurück zum Zitat Brecelj J, Strucl M, Zidar I, Tekavcic-Pompe M (2002) Pattern ERG and VEP maturation in schoolchildren. Clin Neurophysiol 113:1764–1770CrossRefPubMed Brecelj J, Strucl M, Zidar I, Tekavcic-Pompe M (2002) Pattern ERG and VEP maturation in schoolchildren. Clin Neurophysiol 113:1764–1770CrossRefPubMed
25.
Zurück zum Zitat Cohen ME, Duffner PK (1983) Visual-evoked responses in children with optic gliomas, with and without neurofibromatosis. Child Brain 10:99–111 Cohen ME, Duffner PK (1983) Visual-evoked responses in children with optic gliomas, with and without neurofibromatosis. Child Brain 10:99–111
26.
Zurück zum Zitat Groswasser Z, Kriss A, Halliday AM, McDonald WI (1985) Pattern- and flash-evoked potentials in the assessment and management of optic nerve gliomas. J Neurol Neurosurg Psychiatry 48:1125–1134CrossRefPubMed Groswasser Z, Kriss A, Halliday AM, McDonald WI (1985) Pattern- and flash-evoked potentials in the assessment and management of optic nerve gliomas. J Neurol Neurosurg Psychiatry 48:1125–1134CrossRefPubMed
27.
Zurück zum Zitat Lund AM, Skovby F (1991) Optic gliomas in children with neurofibromatosis type 1. Eur J Pediatr 150:835–838CrossRefPubMed Lund AM, Skovby F (1991) Optic gliomas in children with neurofibromatosis type 1. Eur J Pediatr 150:835–838CrossRefPubMed
28.
Zurück zum Zitat Wenzel D, Brandl U, Beck JD, Cedzich C, Albert F (1988) Visual evoked potentials in tumors from orbita to occipital lobe in childhood. Neurosurg Rev 11:279–286 Wenzel D, Brandl U, Beck JD, Cedzich C, Albert F (1988) Visual evoked potentials in tumors from orbita to occipital lobe in childhood. Neurosurg Rev 11:279–286
29.
Zurück zum Zitat Jabbari B, Maitland CG, Morris LM, Morales J, Gunderson CH (1985) The value of visual evoked potential as a screening test in neurofibromatosis. Arch Neurol 42:1072–1074CrossRefPubMed Jabbari B, Maitland CG, Morris LM, Morales J, Gunderson CH (1985) The value of visual evoked potential as a screening test in neurofibromatosis. Arch Neurol 42:1072–1074CrossRefPubMed
30.
Zurück zum Zitat Siatkowski RM (2006) VEP testing and visual pathway gliomas: not quite ready for prime time. J AAPOS 10:293–295CrossRefPubMed Siatkowski RM (2006) VEP testing and visual pathway gliomas: not quite ready for prime time. J AAPOS 10:293–295CrossRefPubMed
31.
Zurück zum Zitat Kelly JP, Leary S, Khanna P, Weiss AH (2012) Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas. Ophthalmology 119:1231–1237CrossRefPubMed Kelly JP, Leary S, Khanna P, Weiss AH (2012) Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas. Ophthalmology 119:1231–1237CrossRefPubMed
32.
Zurück zum Zitat Ammendola A, Ciccone G, Ammendola E (2006) Utility of multimodal evoked potentials study in neurofibromatosis type 1 of childhood. Pediatr Neurol 34:276–280CrossRefPubMed Ammendola A, Ciccone G, Ammendola E (2006) Utility of multimodal evoked potentials study in neurofibromatosis type 1 of childhood. Pediatr Neurol 34:276–280CrossRefPubMed
33.
Zurück zum Zitat Yerdelen D, Koc F, Durdu M, Karakas M (2011) Electrophysiological findings in neurofibromatosis type 1. J Neurol Sci 306:42–48CrossRefPubMed Yerdelen D, Koc F, Durdu M, Karakas M (2011) Electrophysiological findings in neurofibromatosis type 1. J Neurol Sci 306:42–48CrossRefPubMed
34.
Zurück zum Zitat Rossi LN, Pastorino G, Scotti G, Gazocchi M, Maninetti MM, Zanolini C, Chiodi A (1994) Early diagnosis of optic glioma in children with neurofibromatosis type 1. Child Nerv Syst 10:426–429CrossRef Rossi LN, Pastorino G, Scotti G, Gazocchi M, Maninetti MM, Zanolini C, Chiodi A (1994) Early diagnosis of optic glioma in children with neurofibromatosis type 1. Child Nerv Syst 10:426–429CrossRef
35.
Zurück zum Zitat Iannaccone A, McCluney RA, Brewer VR, Spiegel PH, Taylor JS, Kerr NC, Pivnick EK (2002) Visual evoked potentials in children with neurofibromatosis type 1. Doc Ophthalmol 105:63–81CrossRefPubMed Iannaccone A, McCluney RA, Brewer VR, Spiegel PH, Taylor JS, Kerr NC, Pivnick EK (2002) Visual evoked potentials in children with neurofibromatosis type 1. Doc Ophthalmol 105:63–81CrossRefPubMed
36.
Zurück zum Zitat Moradi P, Robson AG, Rose GE, Holder GE (2008) Electrophysiological monitoring in a patient with an optic nerve glioma. Doc Ophthalmol 117:171–174CrossRefPubMed Moradi P, Robson AG, Rose GE, Holder GE (2008) Electrophysiological monitoring in a patient with an optic nerve glioma. Doc Ophthalmol 117:171–174CrossRefPubMed
37.
Zurück zum Zitat Brecelj J, Stim-Kranjc B, Skrbec M (2000) Visual electrophysiology in children with tumours affecting the visual pathway. Case reports. Doc Ophthalmol 101:125–154CrossRefPubMed Brecelj J, Stim-Kranjc B, Skrbec M (2000) Visual electrophysiology in children with tumours affecting the visual pathway. Case reports. Doc Ophthalmol 101:125–154CrossRefPubMed
38.
Zurück zum Zitat Holder GE, Gale RP, Acheson JF, Robson AG (2009) Electrodiagnostic assessment in optic nerve disease. Curr Opin Neurol 22:3–10CrossRefPubMed Holder GE, Gale RP, Acheson JF, Robson AG (2009) Electrodiagnostic assessment in optic nerve disease. Curr Opin Neurol 22:3–10CrossRefPubMed
39.
Zurück zum Zitat Chang BC, Mirabella G, Yagev R, Banh M, Mezer E, Parkin PC, Westall CA, Buncic JR (2007) Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials. Invest Ophthalmol Vis Sci 48:2895–2902CrossRefPubMed Chang BC, Mirabella G, Yagev R, Banh M, Mezer E, Parkin PC, Westall CA, Buncic JR (2007) Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials. Invest Ophthalmol Vis Sci 48:2895–2902CrossRefPubMed
40.
Zurück zum Zitat Trisciuzzi MT, Riccardi R, Piccardi M, Iarossi G, Buzzonetti L, Dickmann A, Colosimo CJ, Ruggiero A, Di Rocco C, Falsini B (2004) A fast visual evoked potential method for functional assessment and follow-up of childhood optic gliomas. Clin Neurophysiol 115:217–226CrossRefPubMed Trisciuzzi MT, Riccardi R, Piccardi M, Iarossi G, Buzzonetti L, Dickmann A, Colosimo CJ, Ruggiero A, Di Rocco C, Falsini B (2004) A fast visual evoked potential method for functional assessment and follow-up of childhood optic gliomas. Clin Neurophysiol 115:217–226CrossRefPubMed
41.
Zurück zum Zitat Falsini B, Ziccardi L, Lazzareschi I, Ruggiero A, Placentino L, Dickmann A, Liotti L, Piccardi M, Balestrazzi E, Colosimo C, Di Rocco C, Riccardi R (2008) Longitudinal assessment of childhood optic gliomas: relationship between flicker visual evoked potentials and magnetic resonance imaging findings. J Neurooncol 88:87–96CrossRefPubMed Falsini B, Ziccardi L, Lazzareschi I, Ruggiero A, Placentino L, Dickmann A, Liotti L, Piccardi M, Balestrazzi E, Colosimo C, Di Rocco C, Riccardi R (2008) Longitudinal assessment of childhood optic gliomas: relationship between flicker visual evoked potentials and magnetic resonance imaging findings. J Neurooncol 88:87–96CrossRefPubMed
43.
Zurück zum Zitat Chang L, El-Dairi MA, Frempong TA, Burner EL, Bhatti MT, Young TL, Leigh F (2010) Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas. J AAPOS 14:511–517CrossRefPubMed Chang L, El-Dairi MA, Frempong TA, Burner EL, Bhatti MT, Young TL, Leigh F (2010) Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas. J AAPOS 14:511–517CrossRefPubMed
44.
Zurück zum Zitat Avery RA, Liu GT, Fisher MJ, Quinn GE, Belasco JB, Phillips PC, Maguire MG, Balcer LJ (2011) Retinal nerve fiber layer thickness in children with optic pathway gliomas. Am J Ophthalmol 151:542–549CrossRefPubMed Avery RA, Liu GT, Fisher MJ, Quinn GE, Belasco JB, Phillips PC, Maguire MG, Balcer LJ (2011) Retinal nerve fiber layer thickness in children with optic pathway gliomas. Am J Ophthalmol 151:542–549CrossRefPubMed
45.
Zurück zum Zitat Segal L, Darvish-Zargar M, Dilenge ME, Ortenberg J, Polomeno RC (2010) Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients. J AAPOS 14:155–158CrossRefPubMed Segal L, Darvish-Zargar M, Dilenge ME, Ortenberg J, Polomeno RC (2010) Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients. J AAPOS 14:155–158CrossRefPubMed
46.
Zurück zum Zitat Blazo MA, Lewis RA, Chintagumpala MM, Frazier M, McCluggage C, Plon SE (2004) Outcomes of systematic screening for optic pathway tumors in children with neurofibromatosis type 1. Am J Med Genet A 127:224–229CrossRef Blazo MA, Lewis RA, Chintagumpala MM, Frazier M, McCluggage C, Plon SE (2004) Outcomes of systematic screening for optic pathway tumors in children with neurofibromatosis type 1. Am J Med Genet A 127:224–229CrossRef
47.
Zurück zum Zitat Dhermain FG, Hau P, Lanfermann H, Jacobs AH, Van Den Bent MJ (2010) Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas. Lancet Neurol 9:906–920CrossRefPubMed Dhermain FG, Hau P, Lanfermann H, Jacobs AH, Van Den Bent MJ (2010) Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas. Lancet Neurol 9:906–920CrossRefPubMed
48.
Zurück zum Zitat Jost SC, Ackerman JW, Garbow JR, Manwaring LP, Gutmann DH, McKinstry RC (2008) Diffusion-weighted and dynamic contrast-enhanced imaging as markers of clinical behavior in children with optic pathway glioma. Pediatr Radiol 38:1293–1299CrossRefPubMed Jost SC, Ackerman JW, Garbow JR, Manwaring LP, Gutmann DH, McKinstry RC (2008) Diffusion-weighted and dynamic contrast-enhanced imaging as markers of clinical behavior in children with optic pathway glioma. Pediatr Radiol 38:1293–1299CrossRefPubMed
49.
Zurück zum Zitat Parsa CF (2012) Why visual function does not correlate with optic glioma size or growth. Arch Ophthalmol 130:521–522CrossRefPubMed Parsa CF (2012) Why visual function does not correlate with optic glioma size or growth. Arch Ophthalmol 130:521–522CrossRefPubMed
51.
Zurück zum Zitat Liu GT, Malloy P, Needle M, Phillips P (1995) Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials. Pediatr Neurol 12:89–90CrossRefPubMed Liu GT, Malloy P, Needle M, Phillips P (1995) Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials. Pediatr Neurol 12:89–90CrossRefPubMed
Metadaten
Titel
Role of visual evoked potentials in the assessment and management of optic pathway gliomas in children
verfasst von
C. Van Mierlo
W. Spileers
E. Legius
I. Casteels
C. Cassiman
Publikationsdatum
01.12.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Documenta Ophthalmologica / Ausgabe 3/2013
Print ISSN: 0012-4486
Elektronische ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-013-9399-5

Weitere Artikel der Ausgabe 3/2013

Documenta Ophthalmologica 3/2013 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.